Diet-drug makers soar on FDA nod By: MarketWatch December 08, 2010 at 11:25 AM EST Shares of diet drug makers Orexigen, Vivus and Arena are soaring on news that a FDA advisory panel has recommended the agency approve Orexigen’s new diet pill Contrave. Read More >> Related Stocks: Johnson & Johnson Macy's Vivus Inc